ID   DM105
AC   CVCL_F867
SY   Duke Melanoma 105
DR   Wikidata; Q54831195
RX   PubMed=2404572;
RX   PubMed=2785141;
CC   From: Duke University Medical Center; Durham; USA.
CC   HLA typing: A*01,10; B*18,53; C*01,02 (PubMed=2404572).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
RX   PubMed=2404572;
RA   Crowley, Nancy J.
RA   Slingluff, Craig L. Jr.
RA   Darrow, Timothy L.
RA   Seigler, Hilliard Foster
RT   "Generation of human autologous melanoma-specific cytotoxic T-cells
RT   using HLA-A2-matched allogeneic melanomas.";
RL   Cancer Res. 50:492-498(1990).
//
RX   PubMed=2785141; DOI=10.4049/jimmunol.142.9.3329;
RA   Darrow, Timothy L.
RA   Slingluff, Craig L. Jr.
RA   Seigler, Hilliard Foster
RT   "The role of HLA class I antigens in recognition of melanoma cells by
RT   tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor
RT   antigens.";
RL   J. Immunol. 142:3329-3335(1989).
//